During the past decade, Toledo Clinic Cancer Centers-Monroe conducted 62 clinical trials. In the 10-year time frame, 62 clinical trials started and 61 clinical trials were completed, i.e. on average, 98.4% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 31 clinical trials were completed. i.e. 119.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Toledo Clinic Cancer Centers-Monroe" #1 sponsor was "National Cancer Institute (NCI)" with 72 trials, followed by "Alliance for Clinical Trials in Oncology" with 20 trials sponsored, "SWOG Cancer Research Network" with 14 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 10 trials sponsored and "GOG Foundation" with 10 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Toledo Clinic Cancer Centers-Monroe" #1 collaborator was "National Cancer Institute (NCI)" with 49 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator and "NCIC Clinical Trials Group" with 5 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Toledo Clinic Cancer Centers-Monroe" are "Recurrent Breast Carcinoma" (9 trials), "Stage IV Breast Cancer AJCC v6 and v7" (6 trials), "Stage IV Cutaneous Melanoma AJCC v6 and v7" (6 trials), "Clear Cell Renal Cell Carcinoma" (5 trials) and "Invasive Breast Carcinoma" (5 trials). Many other conditions were trialed in "Toledo Clinic Cancer Centers-Monroe" in a lesser frequency.

Most popular intervention types in "Toledo Clinic Cancer Centers-Monroe" are "Drug" (106 trials), "Other" (86 trials), "Biological" (64 trials), "Procedure" (26 trials) and "Radiation" (9 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (53 trials), "Quality-of-Life Assessment" (37 trials), "Bevacizumab" (16 trials), "Computed Tomography" (16 trials) and "Biospecimen Collection" (15 trials). Other intervention names were less common.

The vast majority of trials in "Toledo Clinic Cancer Centers-Monroe" are 104 trials for "All" genders, 14 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Toledo Clinic Cancer Centers-Monroe". undefined are not yet recruiting, 31 are recruiting, 54 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Toledo Clinic Cancer Centers-Monroe, 1 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Toledo Clinic Cancer Centers-Monroe, 6 "Phase 1" clinical trials were conducted, 58 "Phase 2" clinical trials and 63 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".